Literature DB >> 20003701

The diagnostic efficacy of fine-needle aspiration using cytology and culture in tuberculous lymphadenitis.

E P Asimacopoulos1, M Berry, B Garfield, M Roesner, A Jepson, J McCarthy, O M Kon.   

Abstract

OBJECTIVE: To retrospectively assess the diagnostic efficacy of fine-needle aspiration (FNA) using cytological and microbiological examinations in tuberculous lymphadenitis.
METHODS: Patients with tuberculous lymphadenitis treated at St Mary's Hospital, London, between January 2001 and June 2007 were identified. The cytological and microbiological reports of 97 patients were found. The criteria for a definite diagnosis of tuberculous lymphadenitis were based on a compatible clinical history, tuberculin positivity and either an indicative cytological result or positive culture.
RESULTS: In 77 of the 97 (79%) cases, FNA cytology showed evidence of a tuberculous process. In 65 cases, Mycobacterium tuberculosis was cultured from the aspirates, and 54 of these 65 cases showed corresponding cytological evidence of a tuberculous process; 23 cases were diagnosed by cytology but not microbiology, while 11 cases were diagnosed by microbiology but not cytology.
CONCLUSION: Cytological and microbiological results appeared to correlate well, but each also gives an exclusive diagnosis. When combining both modalities, the diagnostic efficacy of FNA rises to 91%. A definitive microbiological diagnosis was achieved in 67% of cases and provided information on drug susceptibility. We conclude that samples should be provided for both cytological and microbiological examination when using FNA to diagnose possible tuberculous lymphadenitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20003701

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Role of cytomorphology in differentiating sarcoidosis and tuberculosis in subjects undergoing endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Valliappan Muthu; Nalini Gupta; Sahajal Dhooria; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Ashutosh Nath Aggarwal; Ritesh Agarwal
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

2.  Initial work-up for cervical lymphadenopathy: back to basics.

Authors:  Woo-Jin Jeong; Min-Woo Park; Sung Joon Park; Soon-Hyun Ahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-30       Impact factor: 2.503

3.  Performance of a commercial nucleic acid amplification test with extrapulmonary specimens for the diagnosis of tuberculosis.

Authors:  C Piersimoni; S Bornigia; G Gherardi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-24       Impact factor: 3.267

4.  Cervical tuberculous lymphadenitis: diagnosis and demographics, a five-year case series in the UK.

Authors:  D Moualed; M Robinson; A Qureishi; P Gurr
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

5.  Clinical Characteristics and Treatment Outcomes of Definitive Versus Standard Anti-Tuberculosis Therapy in Patients with Tuberculous Lymphadenitis.

Authors:  Yousang Ko; Changwhan Kim; Yong Bum Park; Eun-Kyung Mo; Jin-Wook Moon; Sunghoon Park; Yun Su Sim; Ji Young Hong; Moon Seong Baek
Journal:  J Clin Med       Date:  2019-06-07       Impact factor: 4.241

6.  Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis.

Authors:  Katherine Antel; Jenna Oosthuizen; Francois Malherbe; Vernon J Louw; Mark P Nicol; Gary Maartens; Estelle Verburgh
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.